copanlisib April 12, 2017 copanlisib Trade Name Orphan Indication Splenic marginal zone lymphoma USA Market Approval USA USA Designation Date 2017-02-07 00:00:00 Sponsor Bayer HealthCare Pharmaceuticals, Inc.;100 Bayer Boulevard, P. O. Box 915;Hanover, New Jersey, 07981
